137 related articles for article (PubMed ID: 46240)
21. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
[TBL] [Abstract][Full Text] [Related]
22. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.
Liu MC; Proud D; Lichtenstein LM; MacGlashan DW; Schleimer RP; Adkinson NF; Kagey-Sobotka A; Schulman ES; Plaut M
J Immunol; 1986 Apr; 136(7):2588-95. PubMed ID: 2419444
[TBL] [Abstract][Full Text] [Related]
23. The effect of indomethacin on immunologic release of histamine and sulfidopeptide leukotrienes from human bronchus and lung parenchyma.
Undem BJ; Pickett WC; Lichtenstein LM; Adams GK
Am Rev Respir Dis; 1987 Nov; 136(5):1183-7. PubMed ID: 2445231
[TBL] [Abstract][Full Text] [Related]
24. Induction of histamine release and desensitization in human leukocytes. Effect of anaphylatoxin.
Petersson BA; Nilsson A; Stålenheim G
J Immunol; 1975 May; 114(5):1581-4. PubMed ID: 47368
[TBL] [Abstract][Full Text] [Related]
25. Non-immunological release of slow-reacting substance from guinea-pig lungs.
Piper PJ; Seale JP
Br J Pharmacol; 1979 Sep; 67(1):67-72. PubMed ID: 91403
[TBL] [Abstract][Full Text] [Related]
26. Complement-induced histamine release from human basophils. III. Effect of pharmacologic agents.
Hook WA; Siraganian RP
J Immunol; 1977 Feb; 118(2):679-84. PubMed ID: 65434
[TBL] [Abstract][Full Text] [Related]
27. Diisopropylfluorophosphate-evoked inhibition of anaphylactic histamine release from human skin: decrease of the inhibition by storing the skin specimens.
Yamamoto S; Greaves MW
Acta Derm Venereol; 1979; 59(2):121-4. PubMed ID: 84487
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of histamine and SRS-A from monkey lung tissue by chlorophenesin.
Malley A; Baecher L
J Immunol; 1971 Aug; 107(2):586-8. PubMed ID: 4105542
[No Abstract] [Full Text] [Related]
29. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP.
Orange RP; Kaliner MA; Laraia PJ; Austen KF
Fed Proc; 1971; 30(6):1725-9. PubMed ID: 4108129
[No Abstract] [Full Text] [Related]
30. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 4th communication: effects on histamine release from human leukocytes and from human and monkey lung fragments.
Yanagihara Y; Abe T; Tsuriya Y; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):84-7. PubMed ID: 2452641
[TBL] [Abstract][Full Text] [Related]
31. [Effect of prostaglandins on anaphylactic release of histamine and slow reacting substance of anaphylaxis (SR -A) from guinea pig lung tissues (author's transl)].
Kitamura S; Ishihara Y; Izumi T; Sugiyama Y; Hayashi R; Hsu LH
Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Jul; 18(7):447-52. PubMed ID: 6162989
[No Abstract] [Full Text] [Related]
32. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
[TBL] [Abstract][Full Text] [Related]
34. Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic releas of histamine an slow-reacting substance of anaphylaxis (SRS-A).
Orange RP; Stechschulte DJ; Austen KF
J Immunol; 1970 Nov; 105(5):1087-95. PubMed ID: 4099046
[No Abstract] [Full Text] [Related]
35. Unique modulation of the immunological release of slow-reacting substance of anaphylaxis (SRS-A) from bovine lung.
Burka JF; Eyre P
Monogr Allergy; 1977; 12():241-4. PubMed ID: 335217
[No Abstract] [Full Text] [Related]
36. Basic characteristics of human lung mast cell desensitization.
MacGlashan D; Lichtenstein LM
J Immunol; 1987 Jul; 139(2):501-5. PubMed ID: 2439588
[TBL] [Abstract][Full Text] [Related]
37. Effect of inhibitors of prostaglandin synthesis and prostaglandins E2 and F2alpha on the immunologic release of mediators of inflammation from actively sensitized guinea-pig lung.
Hitchcock M
J Pharmacol Exp Ther; 1978 Nov; 207(2):630-40. PubMed ID: 712645
[TBL] [Abstract][Full Text] [Related]
38. [Release of histamine and slow reacting substance of anaphylaxis (SRS-A) from the sensitized guinea-pig lungs. 3. Effects of prostaglandin E2 and F2-alpha].
Kitamura S; Ishihara Y; Sasaki K; Shimizu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1976 Nov; 14(11):656-62. PubMed ID: 64636
[No Abstract] [Full Text] [Related]
39. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE.
White MV; Igarashi Y; Lundgren JD; Shelhamer J; Kaliner M
J Immunol; 1991 Jul; 147(2):667-73. PubMed ID: 1712816
[TBL] [Abstract][Full Text] [Related]
40. Chemical mediators of anaphylaxis (histamine, 5-HT, and SRS-A) released from horse lung and leukocytes in vitro.
Burka JF; Deline TR; Holroyde MC; Eyre P
Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):379-88. PubMed ID: 59377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
